CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
Fee revenue, net		$ 23,334	$ 49,818	$ 49,458
Product revenue	38,267		38,267
Cost of sales product	24,369		24,369
Gross profit	13,898	23,334	63,716	49,458
Operating Expenses:
Administrative and management fees (including $3,072,264 and $3,116,681 stock based compensation for the three and six months ended June 30, 2013)	3,141,944	34,888	3,251,861	60,788
Professional and consulting fees (including $44,417 and $104,334 stock based compensation for the three and six months ended June 30, 2013, respectively)	64,286	5,050	153,205	7,400
Commissions			31,200	8,512
Rent and other occupancy costs	15,031	5,957	18,783	11,683
Advertising and promotion	5,227		8,871
Other general and administartive expenses	21,029	21,209	47,080	33,043
Total operating expenses	3,247,517	67,104	3,511,000	121,426
Operating loss	(3,233,619)	(43,770)	(3,447,284)	(71,968)
Other Income (Expense):
Interest expense	(92,630)	(46,812)	(122,560)	(92,936)
Derivative liability (expense) income	(25,200)	(26,668)	(30,293)	18,044
Gain on deconsolidation of subsidiary		62,636		62,636
Total other expense, net	(117,830)	(10,844)	(152,853)	(12,256)
Net loss	(3,351,449)	(54,614)	(3,600,137)	(83,529)
Less: net loss attributable to noncontrolling interest		413		695
Net loss attributable to Mediswipe, Inc.	$ (3,351,449)	$ (54,201)	$ (3,600,137)	$ (83,529)
Basic and diluted loss attributable to Mediswipe, Inc. common shareholders, per share	$ (0.01)	$ 0.00	$ (0.01)	$ 0.00
Weighted average number of common shares outstanding basic and diluted	473,220,659	395,033,751	469,983,005	394,982,232